Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $1.9350 (4.59%) ($1.9250 - $1.9350) on Fri. May. 13, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.58% (three month average) | RSI | 36 | Latest Price | $1.9350(4.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -11.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) VYM(93%) DRIV(95%) XLB(84%) EDOC(83%) VWO(75%) | Factors Impacting CGEN price | CGEN will decline at least -2.29% in a week (0% probabilities). IDRV(85%) IGOV(43%) SPLV(62%) ICLN(85%) SHY(0%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.29% (StdDev 4.58%) | Hourly BBV | 0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.67(-1064.86%) | Resistance Level | $2.24 | 5 Day Moving Average | $1.87(3.48%) | 10 Day Moving Average | $2.06(-6.07%) | 20 Day Moving Average | $2.24(-13.62%) | To recent high | -43.9% | To recent low | 12.8% | Market Cap | $160m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |